Improved stool DNA integrity method for early colorectal cancer diagnosis

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2553-2560

  Rengucci, Claudia ^a   De Maio, Giulia ^a   Menghi, Maura ^b   Scarpi, Emanuela ^a   Guglielmo, Simona ^c   Fusaroli, Pietro ^c   Caletti, Giancarlo ^c   Saragoni, Luca ^d   Casadei Gardini, Andrea ^a   Zoli, Wainer ^a   Falcini, Fabio ^a   Amadori, Dino ^a   Calistri, Daniele ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b Diatech Pharmacogenetics   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER DIAGNOSIS; CAPILLARY ELECTROPHORESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; DNA INTEGRITY ANALYSIS; EARLY DIAGNOSIS; EXTRACTION; FECES ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; CHEMISTRY; COLORECTAL TUMOR; FECES; GENETICS; MASS SCREENING;

COLORECTAL NEOPLASMS; DNA; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; MALE; MASS SCREENING;

EID: 84920140215     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0379     Document Type: Article

References (24)

1. Garcia-Bilbao A, Armananzas R, Ispizua Z, Calvo B, Alonso-Varona A, Inza I, et al. Identification of a biomarker panel for colorectal cancer diagnosis. BMC Cancer 2012;12:43.
2. Fearon ER, Vogelstein B. Agenetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
3. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
4. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-607.
5. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
6. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
7. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
8. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screeningpopulation. Gastroenterology 2008;135:82-90.
9. Yeazel MW, Church TR, Jones RM, Kochevar LK, Watt GD, Cordes JE, et al. Colorectal cancer screening adherence in a general population. Cancer Epidemiol Biomarkers Prev 2004;13:654-57.
10. Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med 2004;38:536-50.
11. Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med 2001;32:502-13.
12. Moawad FJ, Maydonovitch CL, Cullen PA, Barlow DS, Jenson DW, Cash BD. CT colonography may improve colorectal cancer screening compliance. AJR Am J Roentgenol 2010;195:1118-23.
13. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
14. Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, et al. Molecular tests for colorectal cancer screening. Clin Colorectal Cancer 2011;10:8-23.
15. Ahlquist DA. Molecular detection of colorectal neoplasia. Gastroenterology 2010;138:2127-39.
16. Calistri D, Rengucci C, Bocchini R, Saragoni L, Zoli W, Amadori D. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 2003,1:377-83.
17. Calistri D, Rengucci C, Lattuneddu A, Francioni G, Polifemo AM, Nanni O, et al. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool. Neoplasia 2004;6:536-40.
18. Calistri D, Rengucci C, Molinari C, Ricci E, Cavargini E, Scarpi E, et al. Quantitative fluorescence determination of long-fragmentDNAin stool as a marker for the early detection of colorectal cancer. Cell Oncol 2009;31:11-17.
19. Calistri D, Rengucci C, Casadei Gardini A, Frassineti GL, Scarpi E, Zoli W, et al. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals. Cancer Epidemiol Biomarkers Prev 2010;19:2647-54.
20. Available from: http://www.nccn.org/professionals/physician-gls/PDF/colorectal-screening.pdf [accessed June 2014].
21. Sonnenberg A, Delcò F, Inadomi JM. Cost effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133:573-84.
22. Burch JA, Soares-Weiser K, St John DJB, Duffy S, Smith S, Kleijnen J, et al. Diagnostic accuracy of fecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007;14:132-37.
23. Song K, Fendrick AM, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. Gastroenterology 2004;126:1270-79.
24. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206.